Publications by authors named "Maria Silvina Bruzzone"

Objective: Conduct an analysis to determine the existence and updating of national essential medicines lists (EMLs) and clinical practice guidelines (CPGs) for the treatment of diabetes in Latin America and the Caribbean (LAC); and compare the medicines included in each country's list and guidelines both with each other and with those of the World Health Organization (WHO).

Methods: Cross-sectional study. EMLs and CPGs for diabetes were found on the websites of the Pan American Health Organization and national health authorities.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Maria Silvina Bruzzone"

  • - Maria Silvina Bruzzone's recent research focuses on evaluating the alignment between essential medicines lists (EMLs) and clinical practice guidelines (CPGs) for diabetes treatment in Latin America and the Caribbean, highlighting the importance of standardized medical protocols in the region.
  • - The study identifies discrepancies and the need for regular updates in national EMLs and CPGs, emphasizing the role of these documents in ensuring access to essential medications and evidence-based treatment practices for diabetes.
  • - By comparing the contents of national EMLs and CPGs with those recommended by the World Health Organization (WHO), Bruzzone's research aims to improve the consistency and quality of diabetes care in LAC, ultimately contributing to better patient outcomes.